Tag: Michael Vodicka

Hemp For Pets Company Up 122% In 2017

Posted on by The INO.com Team

Analysis originally distributed on September 14, 2017 By: Michael Vodicka of Cannabis Stock Trades

Pets are big business in the US and around across the globe.

In 2016 U.S. consumers spent over $67 billion on pet-related products, up 11% from the year before.

While food accounts for the highest percent of spending, pet medications were close behind at $8 billion. Spending on pet medications is expected to grow another 10% in 2017 to $9 billion.

These huge sales numbers have gotten the attention of the cannabis industry. Capturing even a small percent of the pet medication market could mean hundreds of millions in profit.

That's why I am excited to share an early industry leader that most investors have never heard of.

- Sales are up more than 1,000% in the last 12 months.
- Shares have risen 122% since January.

With the cannabis for pets industry still in its early stages - I see plenty of room for growth for this undercover cannabis company. True Leaf Medicine International Ltd. (TRLFF) is a Canadian cannabis company founded in 2013 and headquartered in British Columbia.

Trueleaf

Shares are listed on the Canadian Securities Exchange under the ticker symbol MJ. I see average daily trading volume around 100,000 shares here, so this stock has plenty of liquidity for most investors. Continue reading "Hemp For Pets Company Up 122% In 2017" →

Australian Cannabis Biotech Up 271%

Posted on by The INO.com Team

Analysis originally distributed on August 30, 2017 By: Michael Vodicka of Cannabis Stock Trades

Opioid abuse has quickly grown into a major global epidemic.

While opioids can be great for pain relief, the down side is that they are highly addictive. Recent data shows that opioid abuse and addiction is killing tens of thousands of people every year in just the United States.

Overdose deaths caused by prescription opioids have quadrupled since 1999. From 1999 to 2015, more than 183,000 people have died in the U.S. from overdoses related to prescription opioids.

This is an alarming trend that has both patients and health care professionals asking - are we capable of providing a better alternative?

According to a young biotech located Australia the answer is yes - and the solution comes in the form of cannabis.

If this young cannabis biotech is correct, not only will patients benefit, early shareholders will be rewarded with huge gains.

Let's take a look. Continue reading "Australian Cannabis Biotech Up 271%" →

Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs

Posted on by The INO.com Team

Analysis originally distributed on August 23, 2016 By: Michael Vodicka of Cannabis Stock Trades

MGC Pharmaceuticals (TSX:MXC, OTC:MGCLF) is a young cannabis biotech headquartered in Western Australia that specializes in pharmaceutical product research and development.

MGC

Australian cannabis stocks have been red hot for the last few months.

  • I added Australian-based Cann Group (ASX:CAN) to the members portfolio on July 31 and we're already up 70% in less than three weeks.
  • I added fellow Australian cannabis stock AusCann (OTC:ACNNF) to the member portfolio on June 6 and we're up 55%.

If you want to learn more about our member portfolio click here.

Although the company is incorporated and headquartered in Australia it also has operations in both Israel and Europe.

For example, MGC received two licenses from the Slovenian government to grow, process and trade Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin, in Europe.

The company's founders were leaders in Israel's growing medical cannabis industry. Continue reading "Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs" →

Cann Group Up 81% In 3 Weeks

Posted on by The INO.com Team

Analysis originally distributed on August 16, 2017 By: Michael Vodicka of Cannabis Stock Trades

This week, I want to share AusCann Group Holdings Ltd. (NASDAQ:ACNNF)/ Cann Group (ASX:CAN) with the free newsletter crowd.

This is a stock I rolled out to members two weeks ago as one of our most recent trades. Members will always get the first look at the best ideas and information we have to offer at CST.

Since being added to the CST portfolio, Cann Group has been surging - Cannabis Stock Trades members are up around 75% on this trade.

2nd Australian Cannabis Permit Holder up 99% in 15 Days - More to Come?

Medical cannabis became legal in Australia in November of 2016.

Under the new program, companies interested in entering the industry must apply for and receive a permit from federal regulators to grow and sell cannabis. Continue reading "Cann Group Up 81% In 3 Weeks" →

This Cannabis Innovator Is Down 50% In Two Months - Time to Buy?

Posted on by The INO.com Team

Analysis originally distributed on August 9, 2017 By: Michael Vodicka of Cannabis Stock Trades

A new and innovative business model is emerging in Canada’s cannabis industry. Not only is it a potentially safer way to invest in the highly volatile cannabis sector, it could also be more profitable than investing in individual cannabis companies.

No, it’s not an ETF or a mutual fund. It’s something called streaming – let me explain.

Cannabis Wheaton Income Corp.(CDNX:CBW) is a young Canadian cannabis company headquartered in Vancouver that just went public in early May.

CBW is pioneering a new and innovative business model in Canada’s cannabis industry known as streaming.

CBW

Streaming means providing funding to cannabis companies to help them build and expand operations in exchange for an equity stake and a portion of the cultivation production.

This model comes straight from the gold and silver mining industry. In fact, Cannabis Wheaton is actually named after Wheaton Precious Metals Corp. (NYSE:WPM), now called Wheaton Precious Metals Corp., a pioneer of streaming in Canada’s precious metals industry. Continue reading "This Cannabis Innovator Is Down 50% In Two Months - Time to Buy?" →